Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.5, PACS scored 70.1 — ADUS leads.
Compare another set
ADUS
Addus HomeCare Corporation
Medical Care Facilities · Quality-Growth
74.5
$114.33 · $2.1B
fundamentals as of
Score gap
4.4
ADUS leads
PACS
PACS Group, Inc.
Medical Care Facilities · Quality-Growth
70.1
$43.30 · $6.9B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestADUS20.0x
Fastest growthADUS+23.2%
Strongest balance sheetADUS0.09
Highest qualityPACS63 / 100
Largest discount to fair valueADUS-35%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
PACS
59
Qualityreturns · margins · balance sheet
63
84
Growthrevenue & earnings expansion
89
84
Valuevaluation vs sector peers
62
PACS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
PACS
$155mC
FCF
$121mC
+23.2%A-
Rev
+15.2%B+
0.09B+
D/E
3.05D
20.0xB+
P/E
25.3xB
1.00B+
PEG
1.10B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
PACS
35% below
Price vs fair valuelower is cheaper
197% above
~-1%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~39%/yr
+35%
1-yr DCF upside
-71%
+53%
5-yr DCF upside
-66%
+83%
10-yr DCF upside
-59%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
PACS
Why this score
Short track record
The companies
ADUSAddus HomeCare Corporation
Medical Care Facilities · $114.33 · beta 0.83
Why now
Medical Care Facilities · market cap $2.1b. 8% off the 52-week high of $124.44. Revenue growing +23%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.08 (implying +17% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
PACSPACS Group, Inc.
Medical Care Facilities · $43.30 · beta -0.08
Why now
Medical Care Facilities · market cap $6.9b. 13% off the 52-week high of $49.49. Revenue growing +15%, comfortably above the S&P median. 6 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $59.00 (implying +36% upside).
Moat
ROE 24% is above 15% — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 3.05 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 4.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
ADUS leads PACS by 4.3 points (74.9 to 70.6), its sharpest advantage coming in D/E (grade B+).
Our AI analyst is busy right now, so this verdict is drawn directly from the pillars, grades and DCF above.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where ADUS and PACS diverge
On the headline score the gap is 4.4 points in favor of ADUS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
ValueADUS 83.6 · PACS 61.5ADUS +22.1
GrowthADUS 83.6 · PACS 88.9PACS +5.3
QualityADUS 59.1 · PACS 63.1PACS +4.0
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is ADUS or PACS the better stock?
ADUS scores higher: ADUS 74.5, PACS 70.1 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do ADUS and PACS differ most?
The widest gap is value, where ADUS leads by 22 points on the 0–100 pillar scale. Neither name sweeps: they trade the lead across the three pillars, so the comparison is a trade-off rather than one being better on every measure.
How are ADUS and PACS scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.